We are live on
!
Find out more
FP
Factorial Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.79%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$2.35M
(+2.1%)
Cap. Flow
-$1.16M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
117
New
18
Increased
22
Reduced
33
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3M |
| 2 |
Franklin Resources
BEN
|
+$2.65M |
| 3 |
J.M. Smucker
SJM
|
+$1.94M |
| 4 |
Perrigo
PRGO
|
+$1.36M |
| 5 |
nVent Electric
NVT
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.92M |
| 2 |
AstraZeneca
AZN
|
+$1.26M |
| 3 |
White Mountains Insurance
WTM
|
+$1.17M |
| 4 |
ALOG
Analogic Corp
ALOG
|
+$1.02M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$992K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.08% |
| 2 | Healthcare | 20.71% |
| 3 | Industrials | 14.57% |
| 4 | Technology | 8.98% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Norfolk Southern
NSC
$78.8B
| $4.38M | 3.91% |
29,000
| – | – |
|
2
Teva Pharmaceuticals
TEVA
$35.9B
| $3.72M | 3.33% |
153,000
| – | – |
|
3
Citigroup
C
$222B
| $3.54M | 3.16% |
52,900
| – | – |
|
4
Capital One
COF
$124B
| $3.25M | 2.91% |
35,400
| – | – |
|
|
5
Bristol-Myers Squibb
BMY
$127B
| $3.07M | 2.75% |
+55,500
| New | +$3M |
|
6
Verizon
VZ
$194B
| $3.01M | 2.69% |
59,900
| – | – |
|
7
Eli Lilly
LLY
$1.07T
| $2.97M | 2.65% |
34,800
-5,300
| -13% | -$435K |
|
|
GWR
8
DELISTED
Genesee & Wyoming Inc.
GWR
| $2.76M | 2.47% |
34,000
| – | – |
|
9
Citizens Financial Group
CFG
$30.4B
| $2.75M | 2.46% |
70,700
-5,000
| -7% | -$208K |
|
|
LM
10
DELISTED
Legg Mason, Inc.
LM
| $2.67M | 2.38% |
76,800
+2,000
| +3% | +$75.9K |
|
|
11
Franklin Resources
BEN
$16.9B
| $2.53M | 2.26% |
+79,000
| New | +$2.65M |
|
12
S&P Global
SPGI
$126B
| $2.49M | 2.22% |
12,200
| – | – |
|
13
Dine Brands
DIN
$432M
| $2.26M | 2.02% |
30,200
| – | – |
|
14
Campbell Soup
CPB
$6.51B
| $2.25M | 2.01% |
55,600
+5,400
| +11% | +$210K |
|
15
Travel + Leisure Co
TNL
$4.54B
| $2.25M | 2.01% |
50,800
-6,347
| -11% | -$313K |
|
16
Apple
AAPL
$4.89T
| $2.19M | 1.96% |
47,400
| – | – |
|
17
Bausch Health
BHC
$1.65B
| $2.14M | 1.92% |
92,200
-21,500
| -19% | -$445K |
|
|
HOUS
18
DELISTED
Anywhere Real Estate
HOUS
| $2.07M | 1.85% |
91,000
| – | – |
|
19
Travelers Companies
TRV
$80.8B
| $1.92M | 1.72% |
15,700
| – | – |
|
20
Wells Fargo
WFC
$261B
| $1.86M | 1.67% |
33,600
+5,100
| +18% | +$273K |
|
|
21
J.M. Smucker
SJM
$12.6B
| $1.86M | 1.66% |
+17,300
| New | +$1.94M |
|
22
Vale
VALE
$62.9B
| $1.85M | 1.65% |
144,000
| – | – |
|
23
Valvoline
VVV
$4.97B
| $1.76M | 1.57% |
81,600
+14,000
| +21% | +$296K |
|
24
Gilead Sciences
GILD
$161B
| $1.6M | 1.43% |
22,600
+15,200
| +205% | +$1.07M |
|
|
VIAB
25
DELISTED
Viacom Inc. Class B
VIAB
| $1.48M | 1.32% |
49,000
+13,400
| +38% | +$394K |
|
Similar funds
TC
PBRA
DFS
LPAM
CI
ACA
LIA
CW
Factorial Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Factorial Partners held 117 positions worth $112M, up 2.1% from $110M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Factorial Partners's Q2 2018 filing shows 18 new, 22 increased, 33 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,500 shares worth $3.07M. The largest sale was Merck, an estimated $1.92M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Factorial Partners's largest Q2 2018 buy was Bristol-Myers Squibb: 55,500 shares worth $3.07M.
- Factorial Partners added most to Gilead Sciences in Q2 2018, an estimated $1.07M increase.
- Factorial Partners's biggest Q2 2018 reduction was White Mountains Insurance, cutting an estimated $1.17M.
- Factorial Partners fully exited Merck in Q2 2018, selling an estimated $1.92M.
- Factorial Partners's ten largest holdings make up 29% of its $112M portfolio in Q2 2018.
- Factorial Partners opened 18 new positions and closed 19 in Q2 2018.
- Factorial Partners's portfolio value rose 2.1% quarter-over-quarter to $112M.
Based on Factorial Partners's 13F filing for Q2 2018, filed 1 Aug 2018.